• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NMS
    7.22 0.61(9.23%) Dec 19, 4:00PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (274,158) (220,872) (123,603)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation4,136  8,307  4,614  
    Adjustments To Net Income36,384  39,075  56,109  
    Changes In Accounts Receivables(1,305) -   -  
    Changes In Liabilities22,254  25,586  10,165  
    Changes In Inventories(413) -   -  
    Changes In Other Operating Activities(8,780)(5,777)(547)
    Total Cash Flow From Operating Activities (221,882) (153,681) (53,262)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(8,543)(4,424)(1,452)
    Investments45,000  (45,054) -  
    Other Cash flows from Investing Activities(10,319)(922)(671)
    Total Cash Flows From Investing Activities 26,138   (50,400) (2,123)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock316,321  22,994  255,929  
    Net Borrowings626  (1,454)2,909  
    Other Cash Flows from Financing Activities(3,363)(4,336)(827)
    Total Cash Flows From Financing Activities 313,584   17,204   258,011  
    Effect Of Exchange Rate Changes(40) -   -  
    Change In Cash and Cash Equivalents 117,800   (186,877) 202,626  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.